Less Ads, More Data, More Tools Register for FREE

Pin to quick picksWHIreland Regulatory News (WHI)

  • This share is currently suspended. It was suspended at a price of 3.75
  • There is currently no data for WHI

Senior Appointments

30 Mar 2010 12:37

RNS Number : 4219J
W.H. Ireland Group PLC
30 March 2010
 



WH Ireland Group Plc

 

Appointment of New Heads of Institutional Sales/Trading and Corporate Finance

 

WH Ireland Group plc (AIM:WHI), the financial services group, is delighted to announce two senior appointments to lead its Institutional Sales/Trading and Corporate Finance operations. Both will be joining in the week commencing 12 April 2010.

 

Russell Hooper joins as Head of Institutional Sales/Trading and will be responsible for coordinating the Group's institutional stockbroking business. Previously, Russell has been Head of European Institutional Client Sales Trading and also Head of Pan European Hedge Fund Sales Trading at Merrill Lynch where he spent 15 years in the Institutional Equities division. He graduated in Materials Engineering from Cardiff University. His interests include cricket, rugby (Welsh) and cycling.

 

Chris Fielding joins as Head of Corporate Finance, bringing with him over 20 years' experience in corporate finance as a small/mid cap specialist. Since 2005, Chris has worked at Arden Partners, having previously spent eleven years at Hoare Govett, where he was a director of Corporate Finance. He qualified as a chartered accountant with Price Waterhouse. Chris will be based in the Group's London office and will lead the continued expansion of the corporate finance business. Chris' interests and hobbies include rugby (English), skiing, classic cars, travel and walking.

 

The WH Ireland team already has significant depth of experience and strong regional coverage through John Wakefield (Bristol), Dan Bate (Manchester), James Joyce (London) and their respective teams, supported by the Group's award-winning research team, based in Leeds, headed by Matthew Davis. In line with the Group's strategy, these appointments will further enhance WH Ireland's institutional sales and corporate finance offering.

 

Commenting on the appointments, Richard Ford (CEO) said:

 

"We are delighted to have secured the services of two top calibre individuals both of whom bring substantial skill and experience to the firm. These appointments come at a time when we are seeing a significant uplift in client demand for our corporate stockbroking services where we are looking to build our already strong position in the market. Russell and Chris will continue to drive our business forward and complement our existing Securities business both in London and through our principal regional offices in Manchester, Leeds, Birmingham and Bristol."

 

John Wakefield commented:

 

"The two appointments continue the work already in place to address the aspirations of our corporate client base to gain wider access to sources of capital and to benefit from best of breed advice in our core small/mid cap market."

 

Matthew Davis (Head of Institutional Research) said of the appointments:

 

"Both Chris and Russell bring significant experience, further enhancing WH Ireland's distribution capability, both corporately and institutionally."

 

30 March 2010

 

Enquiries:

 

WH Ireland Tel: 020 7220 1666

Richard Ford

 

Biddicks (Financial PR to WH Ireland) Tel: 020 7448 1000

Zoe Biddick

 

This information is provided by RNS
The company news service from the London Stock Exchange
 
END
 
 
NRAFMGFFMGDGGZM
Date   Source Headline
29th Nov 20217:00 amRNSNotice of Half Year Results
9th Nov 202110:41 amRNSESOT Purchases
26th Oct 20217:00 amRNSESOT Purchases
8th Oct 20217:00 amRNSAppointment of New Chief Financial Officer
21st Sep 20217:00 amRNSDirector Appointment
9th Sep 20217:58 amRNSEmployee Share Plan and PDMR Dealings
9th Sep 20217:00 amRNSESOT Purchases
12th Aug 20216:20 pmRNSResult of AGM
5th Aug 20213:50 pmRNSESOT Purchases
4th Aug 202110:23 amRNSPDMR and PCA shareholdings
26th Jul 20218:54 amRNSIssue of Equity and Total Voting Rights
20th Jul 20217:00 amRNSESOT Purchases
15th Jul 20217:00 amRNSFinal Results and Notice of AGM
5th Jul 20217:00 amRNSUpdate on Final Results
28th Jun 20217:00 amRNSHolding(s) in Company
21st Jun 20217:00 amRNSBoard Change
17th Jun 20217:00 amRNSESOT Purchases
20th May 20217:00 amRNSPDMR and PCA shareholdings
18th May 20217:00 amRNSEmployee Share Option Trust Purchase Plan
4th May 20217:01 amRNSBoard Changes & Participation in NED Share Scheme
4th May 20217:00 amRNSYear End Trading Update
17th Mar 202111:56 amRNSPDMR Dealing
11th Mar 20217:00 amRNSGrant of Options and Issue of Equity
15th Feb 20217:00 amRNSAppointment of NOMAD and Joint Broker
23rd Dec 202011:29 amRNSHolding(s) in Company
23rd Dec 20207:00 amRNSCompletion of Acquisition
22nd Dec 202011:48 amRNSHolding(s) in Company
18th Dec 202010:24 amRNSResult of General Meeting and Total Voting Rights
30th Nov 202010:47 amRNSResult of Placing and Notice of General Meeting
30th Nov 20207:00 amRNSConditional Acquisition & Placing for up to £5.3m
17th Nov 20207:00 amRNSNew Appointment
26th Oct 20207:00 amRNSInterim Results
24th Aug 20207:00 amRNSUpdate on Isle of Man Office
6th Aug 20203:02 pmRNSDirectorate Change
4th Aug 202011:39 amRNSResult of AGM
28th Jul 20201:00 pmRNSAdditional participation in NED Scheme
27th Jul 202012:50 pmRNSHolding(s) in Company
27th Jul 20207:00 amRNSPDMR shareholding
24th Jul 20203:22 pmRNSPDMR shareholding
23rd Jul 20201:40 pmRNSNew Remuneration Policy, Issue of Options & Equity
9th Jul 20207:00 amRNSFinal Results and Notice of AGM
2nd Jul 20207:00 amRNSDirectorate Change
29th Jun 20207:00 amRNSUpdate on Isle of Man Office
20th May 20207:00 amRNSBoard Changes
14th May 20203:47 pmRNSGeneral Update re Discussions
20th Apr 20207:00 amRNSResponse to Press Speculation
2nd Apr 20207:00 amRNSYear End Trading Update
27th Jan 20209:59 amRNSHolding(s) in Company
2nd Jan 20201:57 pmRNSHolding(s) in Company
31st Dec 201912:31 pmRNSTotal Voting Rights

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.